Physician profile
Ahmed Eid
NPI 1407264476
$1,500.27
in general payments reported to CMS, 2019-2025
16 companies · $651 in 2025
The $651 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.46 · 2022: $20.74 · 2023: $245 · 2024: $503 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,399.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $346.02 | 2024-2025 | Fasenra, Tezspire, Airsupra |
| Mylan Specialty L.P. | $280.00 | 2023-2024 | Yupelri |
| Amgen INC. | $141.79 | 2023-2025 | Tezspire |
| Genzyme Corporation | $124.99 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.21 | 2023-2025 | Spiriva Respimat, Ofev, Stiolto Respimat |
| Regeneron Healthcare Solutions, INC. | $84.84 | 2025 | Dupixent |
| Harmony Biosciences LLC | $80.46 | 2021 | |
| Verona Pharma, INC. | $72.32 | 2025 | Ohtuvayre |
| United Therapeutics Corporation | $56.47 | 2024-2025 | Tyvaso |
| Grifols USA, LLC | $54.92 | 2025 | Prolastin-C Liquid |
| Inari Medical, INC. | $47.09 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Inogen, INC. | $30.05 | 2025 | |
| Chiesi USA, INC. | $21.00 | 2025 | Cleviprex |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.74 | 2022 | |
| Merck Sharp & Dohme LLC | $19.02 | 2025 | Zerbaxa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $18.35 | 2023 | Trelegy Ellipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Eid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.